Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,237) with videos related to
Page
of 124
Sort By:
Network Neuroscience (Cambridge, Mass.)
|
April 16, 2019
Changes in structural network topology correlate with severity of hallucinatory behavior in Parkinson's disease
Julie M Hall, Claire O'Callaghan, Alana J Muller, et al.
Pharmacogenomics
|
May 8, 2026
Pharmacogenetics of venlafaxine response in older adults with depression and chronic lower back pain
Martin Kronenbuerger, Leen Magarbeh, Stefan Kloiber, et al.
Cancer Immunology Research
|
February 24, 2021
IDO1 Signaling through GCN2 in a Subpopulation of Gr-1<sup>+</sup> Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization
Souvik Dey, Arpita Mondal, James B DuHadaway, et al.
European Journal of Neurology
|
April 19, 2006
Emergency department delays in acute stroke - analysis of time between ED arrival and imaging
G J Jungehulsing, K Rossnagel, C H Nolte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2005
Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus
L M A J Muller, K J Gorter, E Hak, et al.
Oncogene
|
November 21, 2007
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase
T Banerjee, J B Duhadaway, P Gaspari, et al.
International Journal of Cancer
|
September 11, 2010
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
Saima Hassan, Marguerite Buchanan, Kaushar Jahan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells
Barbara J Muller-Borer, Wayne E Cascio, Gwyn L Esch, et al.
Clinical Genetics
|
October 2, 2009
An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients
R Kohan, I A Cismondi, R Dodelson Kremer, et al.
Stroke
|
October 7, 2000
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke
A M Bakheit, A F Thilmann, A B Ward, et al.
Page
of 124
Search research articles
Search
Showing results (1001-1010 of 1,237) with videos related to
Sort By:
Page
of 124
Network Neuroscience (Cambridge, Mass.)
|
April 16, 2019
Changes in structural network topology correlate with severity of hallucinatory behavior in Parkinson's disease
Julie M Hall, Claire O'Callaghan, Alana J Muller, et al.
Pharmacogenomics
|
May 8, 2026
Pharmacogenetics of venlafaxine response in older adults with depression and chronic lower back pain
Martin Kronenbuerger, Leen Magarbeh, Stefan Kloiber, et al.
Cancer Immunology Research
|
February 24, 2021
IDO1 Signaling through GCN2 in a Subpopulation of Gr-1<sup>+</sup> Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization
Souvik Dey, Arpita Mondal, James B DuHadaway, et al.
European Journal of Neurology
|
April 19, 2006
Emergency department delays in acute stroke - analysis of time between ED arrival and imaging
G J Jungehulsing, K Rossnagel, C H Nolte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2005
Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus
L M A J Muller, K J Gorter, E Hak, et al.
Oncogene
|
November 21, 2007
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase
T Banerjee, J B Duhadaway, P Gaspari, et al.
International Journal of Cancer
|
September 11, 2010
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
Saima Hassan, Marguerite Buchanan, Kaushar Jahan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells
Barbara J Muller-Borer, Wayne E Cascio, Gwyn L Esch, et al.
Clinical Genetics
|
October 2, 2009
An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients
R Kohan, I A Cismondi, R Dodelson Kremer, et al.
Stroke
|
October 7, 2000
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke
A M Bakheit, A F Thilmann, A B Ward, et al.
Page
of 124